Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study

Overview of attention for article published in Frontiers in Cell and Developmental Biology, February 2024

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 1 X post from an account with 3,900 followers.

New Research: Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study: Background: Patients with… https://t.co/hUC1Kzqk46

22 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.